Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy
- Henri Roché
- , Louise Yelle
- , Francesco Cognetti
- , Louis Mauriac
- , Craig Bunnell
- , Joseph Sparano
- , Pierre Kerbrat
- , Jean Pierre Delord
- , Linda Vahdat
- , Ronald Peck
- , David Lebwohl
- , Rana Ezzeddine
- , Hervé Curé
Research output: Contribution to journal › Article › peer-review
213
Scopus
citations